Related references
Note: Only part of the references are listed.Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor
Mee Young Hong et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells
Mee Young Hong et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
Identification of novel androgen receptor target genes in prostate cancer
Unnati Jariwala et al.
MOLECULAR CANCER (2007)
Statin use and the risk of 10 cancers
Patricia F. Coogan et al.
EPIDEMIOLOGY (2007)
Simvastatin potentiates TNF-α-induced apoptosis through the down-regulation of NF-κB-dependent antiapoptotic gene products:: Role of IκBα kinase and TGF-β-activated kinase-1
Kwang Seok Ahn et al.
JOURNAL OF IMMUNOLOGY (2007)
Statin drugs and risk of advanced prostate cancer
Elizabeth A. Platz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism - A randomized controlled trial
Leonard S. Marks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Antimicrobial activities of amino acid derivatives of monascus pigments
Chulyoung Kim et al.
FEMS MICROBIOLOGY LETTERS (2006)
Improving the outcome of patients with castration-resistant prostate cancer through rational drug development
G. Attard et al.
BRITISH JOURNAL OF CANCER (2006)
Persistent intraprostatic androgen concentrations after medical castration in healthy men
Stephanie T. Page et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer
MA Moyad et al.
UROLOGY (2005)
Statins and prostate cancer risk: A case-control study
J Shannon et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: A preliminary report
MS Cyrus-David et al.
JOURNAL OF UROLOGY (2005)
Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor
AJ Mantha et al.
CLINICAL CANCER RESEARCH (2005)
Red yeast rice: a new hypolipidemic drug
M Journoud et al.
LIFE SCIENCES (2004)
The androgen axis in recurrent prostate cancer
JL Mohler et al.
CLINICAL CANCER RESEARCH (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer
MR Graaf et al.
CANCER TREATMENT REVIEWS (2004)
Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein
DJA Jenkins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Molecular biology of the androgen receptor
EP Gelmann
JOURNAL OF CLINICAL ONCOLOGY (2002)
Statin use and the risk of breast and prostate cancer
PF Coogan et al.
EPIDEMIOLOGY (2002)
Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft
D Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Androgen receptor signaling in androgen-refractory prostate cancer
ME Grossmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
An analysis of nine proprietary Chinese red yeast rice dietary supplements: Implications of variability in chemical profile and contents
D Heber et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2001)
Immunoelectron microscopic localization of 3β-hydroxysteroid dehydrogenase and type 5 17β-hydroxysteroid dehydrogenase in the human prostate and mammary gland
G Pelletier et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2001)
Constituents of red yeast rice, a traditional Chinese food and medicine
JY Ma et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2000)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer -: A nested case-control study
L Blais et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
